AVX Pharma Overview

  • Founded
  • 2013
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 4

AVX Pharma General Information

Description

Developer of medicinal drugs designed to offer treatment for ophthalmic diseases. The company's drugs focuses on ocular surface diseases by providing advanced medicinal products, enabling patients to recover faster from dry eye syndrome.

Contact Information

Website
www.avxpharma.com
Formerly Known As
Avizorex Pharma
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Acquirer
Aerie Pharmaceuticals
Primary Office
  • Parc Científic de Barcelona
  • C/Baldiri Reixac 4-8, Torre R
  • 08028 Barcelona
  • Spain
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

AVX Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore AVX Pharma‘s full profile, request access.

Request a free trial

AVX Pharma Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore AVX Pharma‘s full profile, request access.

Request a free trial